MEG
IBB icon

Millstone Evans Group’s iShares Biotechnology ETF IBB Stock Holding History

Millstone Evans Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.53K Hold
15
– – ﹤0.01% 734
2025
Q4 		$2.53K Hold
15
– – ﹤0.01% 731
2025
Q3 		$2.17K Hold
15
– – ﹤0.01% 735
2025
Q2 		$1.9K Hold
15
– – ﹤0.01% 677
2025
Q1 		$1.92K Hold
15
– – ﹤0.01% 703
2024
Q4 		$1.98K Buy
+15
New +$2.11K ﹤0.01% 651

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millstone Evans Group's IBB Position: Q1 2026 in Review

Millstone Evans Group held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 15 shares worth $2.53K. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Millstone Evans Group first reported a position in IBB in Q4 2024 and has held it in 6 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Millstone Evans Group held 15 shares of iShares Biotechnology ETF worth $2.53K as of Q1 2026.
  • Millstone Evans Group left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Millstone Evans Group's portfolio in Q1 2026, its #734 holding.
  • Millstone Evans Group first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Millstone Evans Group's 13F filing for Q1 2026, filed 30 Apr 2026.